Financial News · Live Terminal

Page 361 of 3481

Swiss Market Index Closes Higher Amid Busy Earnings Day

The blue-chip Swiss Market Index ended Tuesday's trading session 1.04% in the green as earnings season remains in full swing amid another quiet day of local economic news.It was a busy earnings day in Switzerland with specialty chemicals company Sika (SIKA.SW), fluid engineering company Sulzer (SUN.SW), and packaging company SIG Group (SIGN.SW) among corporates that reported financial results.Sika gained 9.77% after it raised its 2026 revenue growth guidance to between 3% and 6% in local currencies from the previous 1% to 4%. The company also reaffirmed its medium-term targets for sustainable and profitable growth, as it booked a year-over-year net sales growth of 4% in local currencies to 5.59 billion francs in the first half, while net profit declined to 552.1 million francs from 554.4 million francs."H1'26 EBITDA was 4.3% ahead of consensus (H1'26 sales +2.9% ahead), with margins 26bps higher than consensus ... We highlight that H2'26 organic growth is implied at ~+2.6%, compared with the +2.9% seen in H1'26, all while the comparison base gets ~2ppts easier (from +0.6% in H1'25 to -1.5% in H2'25), which could signify conservatism in the guidance. We expect the shares will perform relatively well today given the accelerated momentum on organic growth," according to analysts at RBC Capital Markets.Meanwhile, Cicor Technologies (CICN.SW) agreed to purchase the Malaysian subsidiary of Singapore-based intelligent energy solutions company EDMI for $15 million to $20 million. The deal is anticipated to complete in the fourth quarter, with the electronic components company also entering into a long-term strategic manufacturing partnership with EDMI. At closing, Cicor's shares were up 3.58%."We welcome the transaction and view it as a significant step toward Cicor achieving its goal of CHF 1bn in revenue by 2028. Following the failed TT acquisition in late 2025, this marks the first M&A transaction of 2026, though we anticipate further deals this year," Baader Helvea Equity Research said in a note. "In our view, management has demonstrated that it pursues acquisitions only when the price and synergy effects make sense for the Cicor Group, and it continues to consistently follow this strategy."In other news, a US appeals court dismissed the lawsuit against Switzerland over the write-down of Credit Suisse's outstanding additional tier 1 bonds during UBS Group's (UBSG.SW) emergency takeover of the collapsed lender, Finews.com and Swiss newspaper Aargauer Zeitung reported. The court ruled that Switzerland has sovereign immunity and beyond the jurisdiction of US courts as it acted in its capacity as a sovereign state rather than as a market participant when the write-down was ordered. UBS shares closed 0.91% lower.Outside Switzerland and in geopolitical news, Iran's foreign ministry said it held talks with counterparts in Saudi Arabia and Oman over the future of the Strait of Hormuz "to establish stability in the region and eliminate the insecurity imposed on the Strait of Hormuz caused by the aggressive actions of the United States," according to a CNBC report. The statement comes after President Donald Trump said the US is having "good talks" with Iran, which denied conducting any direct discussions with the former.

^SSMI$CICN.SW$SIGN.SW$SIKA.SW$SUN.SW$UBSG.SW

Wire11d ago

GSK Licensor's Late-Stage China Study for Risvutatug Rezetecan in Bone Cancer Meets Primary Endpoint

GSK (GSK) licensor Hansoh's phase 3 trial of risvutatug rezetecan in osteosarcoma, the most common primary bone cancer, achieved its primary endpoint in progression-free survival, GSK said Tuesday.The trial, which was conducted in China in patients with osteosarcoma who have progressed or relapsed after receiving at least two prior lines of systemic therapy, showed that the therapy led to a statistically significant improvement in progression-free survival compared with chemotherapy, according to the statement.Hansoh also reported consistent benefit across secondary endpoints like overall survival, GSK added.Safety profile was consistent with previous findings in the same tumor type, with no new safety signals identified, the company said. Hansoh will use the trial data for regulatory submissions in China, GSK said.Price: $53.96, Change: $+1.98, Percent Change: +3.80%

$GSK

Wire11d ago

Hershey Likely to Miss Q2 Revenue Estimates on Soft Consumption Data, RBC Capital Markets Says

Hershey (HSY) is expected to report Q2 revenue below expectations due to soft North American confection consumption trends, RBC Capital Markets said in a note Tuesday.Scanner data for the June quarter indicate a 0.6% decline in consumption at the total company level, driven by a 2.9% decrease in confection, suggesting the company will likely miss consensus estimates this quarter, analysts wrote. The company is scheduled to report its Q2 financial results on Thursday.The investment firm said management will likely reiterate 2026 guidance, although the lower end of the range is "more appropriate" for now.Management has said it is confident in its 2027 setup and highlighted that it has no plans for price investment, believing that prices are in the right place, but will use price-pack architecture to ensure affordable entry points, according to the note.RBC Capital Markets reiterated its sector perform rating on the stock and price target of $212.Price: $182.60, Change: $+2.41, Percent Change: +1.34%

$HSY

Mining & Metals11d ago

Lake Victoria Gold Begins Phase 1 Earthworks at Imwelo Gold Project

Lake Victoria Gold (LVG.V) said Tuesday it started Phase 1 earthworks at its Imwelo Gold Project in Tanzania.The company plans to upgrade the existing access road and prepare the plant site under the initial earthworks program, it said. The project's site camp construction is nearing completion."We are establishing the infrastructure in the order the project requires, while ensuring that early investments, including the camp, continue to serve Imwelo through construction and into operations," said Chief Executive Officer Marc Cernovitch.The company's shares were last seen up C$0.01, or 4%, to C$0.26 on the TSX Venture Exchange.Price: $0.26, Change: $+0.01, Percent Change: +4.00%

$LVG.V

Wire11d ago

Morgan Stanley Raises Hartford Insurance Price Target to $145 From $142, Maintains Equal Weight Rating

Hartford Insurance Group (HIG) has an average rating of overweight and mean price target of $149.52, according to analysts polled by FactSet.Price: $142.37, Change: $+2.23, Percent Change: +1.59%

$HIG

Asia Markets11d ago

German Shares Rally; Mercedes-Benz Climbs Post-H1 Results

German equities rallied on Tuesday, with the blue-chip DAX index closing 0.52% higher, partly driven by Mercedes-Benz Group (MBG.F) after reporting its first-half earnings.RBC Capital Markets viewed the German luxury vehicle manufacturer's second-quarter results positively, noting that its adjusted EBIT of 2.30 billion euros and revenue of 32.06 billion euros surpassed consensus forecasts of 1.65 billion euros and 31.90 billion euros, respectively."Mercedes posted a strong Q2 beat vs consensus, highlighted by Car margins coming in at 4%, above the 3.5% consensus level. While mgmt did temper its '26 Revenue/volume guide for the full year, consensus was already below the prior guide... Importantly, Mercedes monetized EUR400M of its 35% Daimler Truck [DTG.F] stake (its stake would imply ~(Euro)12.5B), representing ~3% of MBG's interest. On the positive side, this does indicate that the company is serious about asset monetization, but it likely will be done over a long period of time considering the relatively small disposition size done in Q2," RBC wrote. Mercedes-Benz Group was up 2.88%, while Daimler Truck increased 3.75% at the end of the trading day.Outside the DAX index, photovoltaic projects developer Helios Solar (HE8.F) made its debut on the Frankfurt Stock Exchange's General Standard segment, opening at 4.15 euros per share.In geopolitical news, Gulf nations are reportedly supporting a proposal from Oman that will allow Iran to collect voluntary passage fees in the Strait of Hormuz to help restore disrupted oil trade, a source told Reuters. The report comes as US President Donald Trump noted "good talks" were underway, while threatening renewed strikes unless negotiations produced results."And while Iran's Foreign Ministry suggested that no formal negotiations were taking place with the US, we saw continued reporting of talks between Iran and Oman on re-opening the Strait of Hormuz," Deutsche Bank Research said. "There was also some more concerning news, not least with Houthi attacks on Saudi oil facilities over the weekend. But overall, the focus on talks sent front-month Brent crude -8.70% lower, while 6-month Brent futures were down -3.29% to $79.67 [per barrel]."Back home, the ifo Institute reported that German export expectations marginally improved in July, even as the industry still struggles with building momentum. The ifo export expectations ticked up to -3.3 points from June's -3.6 points, with increases projected in foreign sales across the electrical equipment, beverage, mechanical engineering, and food manufacturers.

^DAX$DTG.F$HE8.F$MBG.F

International11d ago

Canada Seen Absorbing Latest US Tariffs Despite Sector-Specific Pain, RBC Says

Canada's broader growth outlook remains intact despite last week's proposed 50% US tariffs, with the measures affecting only a small portion of bilateral trade according to RBC Economics.While the broader Canadian economy is expected to remain resilient, the impact is likely to be concentrated in sectors such as plastics, electrical machinery, furniture and home appliance manufacturing, mirroring the sector-specific weakness that followed earlier US Section 232 tariffs on autos and steel, wrote RBC in a Friday note.The new tariffs would affect roughly 5% of Canada's exports to the US, leaving more than 80% duty-free. The average effective US tariff on Canadian imports would rise from about 3% to 5.5%, the bank calculated.Unlike tariffs on products such as aluminum, where Canada supplied a dominant share of US imports and American buyers had limited alternatives, the latest measures target products that account for just 3.7% of US imports in those categories, giving US importers greater scope to source from other suppliers, said RBC.As a consequence, the burden is likely to fall more heavily on Canadian exporters, which have far fewer alternative markets. In 2025, around 81% of Canada's exports of the newly tariffed products were destined for the United States, rising to 92% for plastics and related products.As a result, while the overall macroeconomic impact is expected to remain limited, reducing reliance on the US market will remain a longer-term challenge for Canada, added the bank.

$CXY

Asia Markets11d ago

UK Shares Jump Amid Earnings Influx, US-Iran Talks; Unilever Updates Guidance

London's FTSE 100 closed 0.90% higher on Tuesday as corporate earnings dominated the news, while geopolitical tensions eased.Unilever (ULVR.L), up 8.58%, led the blue-chip index after the consumer goods giant raised its full-year outlook, saying it expects underlying sales growth within its 4% to 6% multi-year guidance range, compared with previous guidance of the low end of that range, while forecasting 3% underlying volume growth."This was a very good quarter for Unilever, with even the bit that didn't go well (food in Europe) playing into management's decision to offload that business," RBC Capital Markets said, noting in-line profit and earnings. "Marketing/sales fell by 10 [basis points], but that hardly seems a big problem in the circumstances. Asia in particular benefitted from solid growth 1H in India (+8% in 2H), China (mid single digit) and Indonesia (+7%)."GSK (GSK.L) grew 4.08% after it reported 3% annual growth in turnover for the first half to 16.04 billion pounds sterling and affirmed its 2026 outlook. The drugmaker also intends to invest 400 million pounds in three years to upgrade its research and development facilities and open a new global research and development center in Cambridge, UK.On the downside, lender Barclays (BARC.L) tumbled 5.52% to become the FTSE 100's worst performer as yearly growth in first-half earnings and better-than-expected second-quarter results were offset by a weaker investment banking performance than US peers."[Second-quarter pretax profit] was a 4% beat vs consensus driven by income and impairments, partially offset by higher-than-expected costs," RBC said in another note. "On a divisional basis, the beat was driven by the IB. On an underlying pre-provision profit basis, there was a 2% beat. ... We expect the focus of today's call will be on the return on investment of an acceleration in strategic cost actions and weaker performance than US peers in the IB."In macro news, the UK's shop price inflation softened to 0.9% year over year in July, from 1.2% a month ago, according to a survey by the British Retail Consortium. The latest reading was below the consensus estimate and three-month average of 1.1%, which BRC Chief Executive Helen Dickinson attributed to promotions on food and alcohol during the FIFA World Cup, discounts on clothing and footwear, and other summer deals.On the geopolitical front, US President Donald Trump suspended attacks on Iran, with a plan to resume "very strong military action" if peace negotiations fall through, Deutsche Bank Research said, citing an interview with Axios. Talks are advancing and there is a good chance of reaching an agreement with Iran, Trump told reporters.

FTSE 100$BARC.L$GSK.L$ULVR.L

Wire11d ago

Market Chatter: OpenAI, Anthropic Push Trump Administration to Expand AI Models Requiring Government Review

Microsoft-backed (MSFT) OpenAI and Amazon-backed (AMZN) Anthropic have pushed to expand the types of AI models requiring government review under a looming Trump administration framework to include those from competitors like Meta Platforms (META) and SpaceX's (SPCX) SpaceXAI, The Information reported, citing sources.OpenAI and Anthropic didn't immediately reply to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $398.97, Change: $+9.86, Percent Change: +2.54%

$AMZN$META$MSFT$SPCX

Asia Markets11d ago

European Stocks Close Higher in Tuesday Trading; Consumer Goods Rally While Tech, Energy Stocks Fall

European stock markets closed higher in Tuesday trading, buoyed by rising consumer goods and automotive stocks, while energy and tech shares continued to fall.The Stoxx Europe 600 gained 0.4%, Germany's DAX increased 0.6%, the FTSE 100 rose 0.9%, France's CAC advanced 0.7%, and the Swiss Market Index closed 1.1% higher.In corporate news, GSK reported Q2 core earnings Tuesday of about 0.50 British pound ($0.67) per share, up from about 0.47 pound a year earlier. Analysts polled by FactSet expected 0.46 pounds.Sales for the quarter ended June 30 were 8.41 billion pounds, up from 7.99 billion pounds a year earlier. Analysts surveyed by FactSet expected 8.25 billion pounds.For 2026, the pharmaceutical company reaffirmed at-constant-exchange-rate guidance for core EPS to increase 7% to 9%, at the lower half of that range, and for turnover to increase 3% to 5%, at the upper half of that range.GSK also said Tuesday it plans to establish a new global research and development facility within Cambridge Biomedical Campus in the UK and spend 400 million pounds over three years to construct the center and upgrade existing laboratories in Ware.Shares of GSK rose 4.2% in London.Barclays reported Q2 earnings Tuesday of 0.167 pound per basic ordinary share, up from 0.117 pound a year earlier.Total income for the quarter ended June 30 was 8.34 billion pounds, up from 7.19 billion pounds a year earlier. Analysts polled by FactSet expected 8.04 billion pounds.The company also said it initiated a share buyback of up to 1 billion pounds, which would commence in Q3.Meanwhile, Chief Financial Officer Anna Cross said Tuesday it is shifting its compensation model toward a Wall Street-style structure by increasing performance-based pay while reducing fixed salaries for senior bankers, according to Bloomberg.The bank's performance-related compensation rose nearly 30% year over year to 1.3 billion British pounds ($1.7 billion) in H1 2026, while salaries increased by less than 1%.Barclays did not immediately respond to' request for comment.Shares of the British bank dropped 6% in London.Unilever reported Q2 turnover Tuesday of 13.05 billion euros ($14.84 billion), compared with 12.57 billion euros a year earlier.Analysts polled by FactSet expected 13 billion euros.Underlying sales for the quarter grew 5.8%, the company said.For 2026, Unilever said it continues to expect underlying sales growth to be within its multi-year guidance range of 4% to 6%.Shares of the consumer goods giant jumped nearly 9% in London.Stellantis has agreed to sell its entire stake in Free2move's car-sharing business to Mutares, the companies said Tuesday.Free2move provides free-floating car-sharing services in Europe and the US. The financial terms of the deal weren't disclosed.Shares of the European automaker increased 1.5% in Paris.HSBC Chief People and Governance Officer Aileen Taylor plans to relocate from London to Hong Kong later this year, Bloomberg reported Tuesday, citing people familiar with the matter.The report said Taylor, a member of HSBC's 13-person group operating committee, will join a growing number of senior executives based in the bank's largest market.HSBC declined to comment when contacted by.Shares of HSBC were off 0.4% in London.BHP and unions representing workers at its Port Hedland iron ore operations ended the latest round of wage negotiations without reaching an agreement, Reuters reported Tuesday.The Combined Ports Unions said negotiations will resume next Tuesday, while the Electrical Trades Union, one of three unions in the group, is due to hold separate talks with BHP on Thursday, the report said.BHP did not immediately respond to' request for comment.Shares of the mining company edged 0.2% higher in London.

Wire11d ago

OpenAI, Anthropic Push Trump Administration to Expand AI Models Requiring Government Review, The Information Reports

$AMZN$META$MSFT$SPCX

Wire11d ago

Amkor Earns Credit for Strong Q2 Execution, Morgan Stanley Says

Amkor Technology (AMKR) has earned credit for its strong Q2 execution, with gross margin and earnings beating expectations, Morgan Stanley said in a report Tuesday."We are giving the company credit for strong execution," the note said, pointing among others to its gross margin running well ahead of schedule.The report said the beat and raise on gross margin and EPS was driven by strength in Computing and Automotive/Industrial and broad-based utilization improvement.The note said estimates also rose on stronger margin execution and an accelerated compute ramp, though the Arizona dilution math partially offset the magnitude of upward revisions.Morgan Stanley edged up its price target to $70 from $69 while maintaining its equal-weight rating.Price: $46.32, Change: $-14.40, Percent Change: -23.71%

$AMKR

Wire11d ago

Kiniksa's Arcalyst Growth Outlook Strengthens, Wedbush Says

Kiniksa Pharmaceuticals International (KNSA) is benefiting from continued momentum for Arcalyst, its treatment for recurrent pericarditis, a condition in which the sac around the heart becomes inflamed in repeated episodes, Wedbush Securities said Tuesday in a report.Arcalyst's growth continues to be driven by broadening prescriber adoption, with more than 5,000 clinicians having used the therapy since launch and returning users accounting for over half of new scripts, Wedbush said.Kiniksa shares face additional upside as Arcalyst's cash generation supports development of the company's pipeline and as newer recurrent pericarditis assets create a path for long-term expansion, the report said.Wedbush highlighted KPL-387, Kiniksa's next-generation treatment candidate, as a "de-risked" opportunity that may strengthen the company's position in IL-1 blockade for recurrent pericarditis while improving the franchise's long-term economicsWedbush increased its price target on Kiniksa's stock to $99 from $72 and maintained its outperform rating.Price: $79.38, Change: $+15.84, Percent Change: +24.93%

$KNSA

Oil & Energy11d ago

Baker Hughes Boosts Long-Term Outlook as LNG, Power Orders Fuel Growth, RBC Says

Baker Hughes (BKR) reported a stronger-than-expected Q2 and raised its long-term industrial energy technology order outlook, supported by surging demand for power-generation equipment and liquefied natural gas infrastructure, RBC Capital Markets strategists said in a note on Monday.RBC analysts said the oilfield services and energy technology firm posted adjusted earnings before interest, taxes, depreciation and amortization of $1.23 billion in Q2, up 6% from the previous quarter and above the top end of its guidance range for the second consecutive period.Free cash flow reached $1.05 billion, more than double RBC's estimate of $498 million, reinforcing management's expectation that cash conversion will approach 50% for the year.Baker Hughes shares gained support from strong momentum in its Industrial & Energy Technology division, which has become a key growth driver as global demand rises for LNG capacity, data-center power and energy infrastructure.RBC said that the company secured $7.1 billion in IET orders during the quarter, exceeding expectations.Power Systems accounted for $2.6 billion of the new orders, covering 2.7 gigawatts of generation capacity. The contracts included turbine and generator equipment for oil and gas operations as well as data-center applications in North America.The company also booked $1.8 billion in LNG equipment orders across projects involving Venture Global's (VG) CP2 facility, Golar LNG's (GLNG) FLNG project and Cheniere Energy's (LNG) Sabine Pass LNG facility.Following the strong order intake, Baker Hughes increased its IET Horizon 2 order target for 2026/28 to more than $45 billion, from a previous target of $40 billion.The energy firm also said it plans to expand power systems revenue capacity to $5 billion per year by 2029, compared with about $1 billion generated in 2025.RBC analysts expect the company's multi-year growth and margin expansion to be driven primarily by IET.For Q3, Baker Hughes forecasted EBITDA of about $1.21 billion, while reaffirming its full-year 2026 EBITDA midpoint of $4.85 billion.The company's implied Q4 outlook assumes Middle East activity remains at Q2 levels, a more cautious stance compared with some industry peers.RBC raised its 2026 EBITDA estimate for Baker Hughes to $4.85 billion, while trimming its 2027 forecast by 1% to $5.39 billion due to modestly lower margin expectations.The research firm introduced a 2028 EBITDA forecast of $5.95 billion, representing growth of about 11% year over year.Price: $58.11, Change: $-2.48, Percent Change: -4.09%

$BKR$GLNG$LNG$VG

US Markets11d ago

Meta Partners With BlackRock Over $14 Billion Data Center Project

Meta Platforms (META) and asset manager BlackRock (BLK) have teamed up to develop a data center campus in El Paso, Texas, at a cost of roughly $14 billion, the companies said Tuesday.Technology giants are ramping up investments to support their artificial intelligence initiatives. Meta is targeting capital expenditures of $125 billion to $145 billion this year, including for data center buildouts.The Facebook and Instagram parent said Tuesday it will invest more than $10 billion in the El Paso facility.Meta intends to use the entire data center campus under an initial four-year lease agreement, with a maximum lease term of 20 years, according to a joint statement.The partnership "allows us to move faster and at greater scale -- pairing our deep expertise in designing and operating world-class data centers with one of the world's leading infrastructure investors," Meta Chief Executive Mark Zuckerberg said.BlackRock-managed funds will own an 80% interest in a venture to be formed with Meta, which will take the remaining 20% stake in it."Companies around the world are looking for long-term strategic partners to help develop their most important projects, and BlackRock is built to meet that need," BlackRock CEO Larry Fink said.Meta, along with Alphabet (GOOG, GOOGL), Amazon.com (AMZN) and Microsoft (MSFT), are expected to spend $650 billion in capex, compared with $410 billion last year, asset management firm Bridgewater Associates said in February.Some companies have sought financing for their AI initiatives, like CoreWeave (CRWV), which in March announced an $8.5 billion loan facility to expand its AI cloud platform.Meta and BlackRock expect to close the deal in the coming days, with an aim to start capacity deployment in 2028.The announcement comes ahead of Meta's second-quarter results, due out after market close on Wednesday. Shares of Meta were flat intraday Tuesday, while those of BlackRock advanced by 3.2%.Price: $592.89, Change: $-0.98, Percent Change: -0.17%

$AMZN$BLK$CRWV$GOOG$GOOGL$META$MSFT

Wire11d ago

GrafTech International Could Benefit From Anti-Dumping Duties, Higher Volumes, Lower Costs, RBC Says

GrafTech International (EAF) could see better pricing, higher volumes and lower costs over time, while possible anti-dumping duties may help improve profitability, though excess supply remains a key risk, RBC Capital Markets said in a note emailed Tuesday.Anti-dumping duties expected by September could reduce US imports and support a longer-term graphite electrode price of about $4,200 to $4,500 per metric ton or more, RBC said, adding that it expects GrafTech's fiscal 2026 volumes to rise 5% to 10%, supported by new orders in the second half and modest growth in global steel demand.RBC also expects lower production costs, forecasting fiscal 2026 cash cost of goods sold at $4,399 per metric ton, down from its previous $4,493 estimate, according to the note.Continued cost cuts and stronger pricing could eventually return GrafTech to profitability and move free cash flow closer to break-even, the investment firm said.RBC kept the company's $7 price target and sector perform rating.Price: $7.57, Change: $-0.23, Percent Change: -2.89%

$EAF

Wire11d ago

Keefe Bruyette & Woods Adjusts PayPal Price Target to $70 From $55, Maintains Outperform Rating

PayPal (PYPL) has an average rating of Hold and mean price target of $49.66, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $58.31, Change: $+2.24, Percent Change: +3.99%

$PYPL

Mining & Metals11d ago

Minaurum Silver Announces Plans to Improve Understanding of Alamos Silver Project Geology

Minaurum Silver (MGG.V) on Tuesday announced two initiatives to advance geological understanding of its Alamos Silver Project in Sonora, Mexico.The company engaged geologist Dr. Paula Montoya, currently attached to the University of Tasmania's Centre for Ore Deposit and Earth Sciences (CODES), to undertake a comprehensive geological study of the Alamos district. Dr. Montoya served as senior exploration geologist at AngloGold Ashanti.Minaurum also contracted PROINFRA, in Sonora, to conduct a down-hole optical televiewer survey on selected drill holes from the company's resource-expansion drilling program."By combining world-class geological research with advanced structural imaging technology, we are building a refined picture of the mineralized system," said chief executive Darrell Rader. "These initiatives will help us identify the most prospective targets, improve drilling efficiency, and continue expanding the mineralized footprint at Alamos and our geological and resource models."Minaurum Silver shares were last seen down C$0.015 to C$0.285 on the TSX Venture Exchange.Price: $0.29, Change: $-0.02, Percent Change: -5.00%

$MGG.V

Wire11d ago

Susquehanna Adjusts PayPal Price Target to $67 From $63, Maintains Positive Rating

$PYPL

Wire11d ago

Faeth Therapeutics' Experimental Cancer Drug Piktor Has Upside Potential, Oppenheimer Says

Faeth Therapeutics' (FTH) investigational cancer drug Piktor has a differentiated potential and may see 24% upside from trial results in Q4, followed by breast cancer data next year that may unlock additional value, Oppenheimer said in a note emailed Tuesday.Oppenheimer said it is estimating risk-adjusted total peak sales of about $1.6 billion.The recent approval by the US Food and Drug Administration of Celcuity's (CELC) Revtorpyk for breast cancer "validates the multi-node mechanism," Oppenheimer said."We believe this validation supports Piktor's probability of success in both breast cancer and endometrial cancer," the note said.The investment firm added Piktor "could capture meaningful share in community oncology settings with efficacy similar to Revtorpyk."Oppenheimer started coverage of Faeth Therapeutics with an outperform rating and $60 price target.Price: $28.44, Change: $-0.80, Percent Change: -2.74%

$FTH

Showing 7201-7220 of 69604

Asia Markets11d ago